Preformulation studies and enabling formulation selection for an insoluble compound at preclinical stage—from in vitro, in silico to in vivo

Abstract The objective of this work is to identify an enabling formulation for an insoluble compound ZL006 with potency of boosting leukocytes after chemotherapy. The low oral bioavailability (